Clinical Trial Update: Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

View source ↗

Summary

A completed clinical trial from AstraZeneca assessed the impact of patient education on cardiovascular risk factors in individuals with type 2 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension
• Type 2 Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Glycemia, Hypertension | Status: COMPLETED